Mavenir Confirms Refocus Strategy on Mobile Core and AI Vision With Expanded Leadership Team to Accelerate AI-Native Network Strategy December 8, 2025
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks December 8, 2025
EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025 December 8, 2025
Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows December 8, 2025
Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting December 8, 2025
OCCI Showcases Commercial Opportunities at the Egyptian-Saudi International Franchise Exhibition July 2, 2026
